Pfizer, Allergan combining in $160 billion deal
Deal, which creates the world's biggest drugmaker, uses a highly controversial method to drastically cut Pfizer's tax tab
Watch CBS News
Deal, which creates the world's biggest drugmaker, uses a highly controversial method to drastically cut Pfizer's tax tab
Transactions such as mergers that result in U.S. companies relocating HQ overseas to avoid taxes just got a little harder
CEO Ian Read is a poster boy for critics who have long complained about the U.S. corporate tax system being unfair
By buying Ireland-based Allergan, Ian Read would cut Pfizer's U.S. tax bill while adding valuable products such as Botox
Botox maker confirms that it has been approached by about a possible merger
Pfizer third-quarter profits fall; more people getting a chance to own Google Glass; plus more MoneyWatch headlines
A big prescription drug insurance plan is dropping Viagra next year, but there are alternatives to the little blue pill